Seroquel restores sensorimotor gating in phencyclidine-treated rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 3, 1996, Pages 1290-1299

  Swerdlow, Neal R ^a   Bakshi, Vaishali ^a   Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CLOZAPINE; DOPAMINE; GLUTAMIC ACID; HALOPERIDOL; PHENCYCLIDINE; QUETIAPINE; RISPERIDONE; SEROTONIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CHOLINERGIC ACTIVITY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; EXTRAPYRAMIDAL SYMPTOM; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOSIS; RAT; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DIBENZOTHIAZEPINES; HALOPERIDOL; MALE; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; RISPERIDONE; STARTLE REACTION;

EID: 0030426257     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. ADDINGTON, D. E., TOEWS, J. A. AND ADDINGTON, J. M.: Risperidone and tardive dyskinesia: A case report. J. Clin. Psychiatry 56: 484-485, 1995.
2. BAKSHI, V. P. AND GEYER, M. A.: Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical olanzapine. Psychopharmacology 122: 198-201, 1995.
3. BAKSHI, V. P., SWERDLOW, N. R. AND GEYER, M. A.: Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J. Pharmacol. Exp. Ther. 271: 787-794, 1994.
4. BOLINO, F., DI MICHELE, V., DI CICCO, L., MANNA, V., DANELUZZO, E. AND CASACCHIA, M.: Sensorimotor gating and habituation evoked by electrocutaneous stimulation in schizophrenia. Biol. Psychiatry 36: 670-679, 1994.
5. BOLINO, F., MANNA, V., DI CICCO, L., DI MICHELE, V., DANELUZZO, E., ROSSI, A. AND CASACCHIA, M.: Startle reflex habituation in functional psychoses: A controlled study. Neurosci. Lett. 145: 126-128, 1992.
6. BRAFF, D. L., GRILLON, C. AND GEYER, M.: Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry 49: 206-215, 1992.
7. BRAFF, D., STONE, C., CALLAWAY, E., GEYER, M., GLICK, I. AND BALI, L.: Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15: 339-343, 1978.
8. CHIODO, L. A. AND BUNNEY, B. S.: Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci. 3: 1607-1619, 1983.
9. COWARD, D. M.: General pharmacology of clozapine. Br. J. Psychiatry 160: suppl. 17, 5-11, 1992.
10. DAVIS, K. L., KAHN, R. S., KO, G. AND DAVIDSON, M.: Dopamine in schizophrenia: A review and reconceptualization. Am. J. Psychiatry 148: 1474-1486, 1991.
11. DAVIS, M., GENDELMAN, D., TISCHLER, M. AND GENDELMAN, P.: A primary acoustic startle circuit: Lesion and stimulation studies. J. Neurosci. 2: 791-805, 1982.
12. FABRE, L. F., JR.: A multicenter, open, pilot trial of ICI 204,636 in hospitalized patients with acute psychotic symptomatology. Proc. Int. Congr. Schizophr. Res. 1993.
13. GEYER, M. A. AND BRAFF, D. L.: Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr. Bull. 13: 643-668, 1987.
14. GEYER, M. A., SWERDLOW, N. R., MANSBACH, R. S. AND BRAFF, D. L.: Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res. Bull. 25: 485-498, 1990. s
15. GOLDSTEIN, J. M., LITWIN, L. C., SUTTON, E. B. AND MALICK, J. B.: Seroquel: Electrophysiological profile of a potential atypical antipsychotic. Psychopharmacology 112: 293-298, 1993.
16. GRAHAM, F.: The more or less startling effects of weak prestimulation. Psychophysiology 12: 238-248, 1975.
17. GRILLON, C., AMELI, R., CHARNEY, D. S., KRYSTAL, J. AND BRAFF, D. L.: Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol. Psychiatry 32: 939-943, 1992.
18. HAMM, A., WEIKE, A., BAUER, U., VAITL, D. AND GALLHOFER, B.: Prepulse inhibition in medicated and unmedicated schizophrenics. Abstr. Soc. Psychophysiol. Res. 1995, p. 11.
19. HIRSCH, S., ARVANITIS, L., MILLER, B. AND SMITH, A.: Seroquel Study Group: A multicentre, double-blind, placebo-controlled comparison of low and high dosage regimens of Seroquel in the treatment of hospitalised patients with acute exacerbation of subchronic or chronic schizophrenia. Eur. Neuropsychopharmacol. 4: 384-385, 1994.
20. HOFFMAN, D. C., DONOVAN, H. AND CASSELLA, J. V.: The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801. Psychopharmacology 111: 339-344, 1993.
21. HOFFMAN, H. S. AND SEARLE, J. L.: Acoustic and temporal factors in the evocation of startle. J. Acoust. Soc. Am. 43: 269-282, 1968.
22. ISON, J. R., MCADAM, D. W. AND HAMMOND, G. R.: Latency and amplitude changes in the acoustic startle reflex produced by variations in auditory prestimulation. Physiol. Behav. 10: 1035-1039, 1973.
23. JAVITT, D. C. AND ZUKIN, S. R.: Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148: 1301-1308, 1991.
24. JOHANSSON, C., JACKSON, D. M. AND SVENSSON, L.: The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat. Psychopharmacology 116: 437-442, 1994.
25. JOHANSSON, C., JACKSON, D. M., ZHANG, J. H. AND SVENSSON, L.: Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: Effects of antipsychotics and other agents in rate. Pharmacol. Biochem. Behav. 52: 649-654, 1995.
26. KANE, J., HONIGFELD, G., SINGER, J. AND MELTZER, H.: Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry 45: 789-796, 1987.
27. KEITH, V. A., MANSBACH, R. S. AND GEYER, M. A.: Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol. Psychiatry 30: 557-566, 1991.
28. KOPALA, L. C. AND HONER, W. G.: Schizophrenia and severe tardive dyskinesia responsive to risperidone. J. Clin. Psychopharmacol. 14: 430-431, 1994.
29. LAURSEN, A. L. AND GERLACH, J.: Antipsychotic effect of remoxipride, a new substituted benzamide with selective antidopaminergic activity. Acta Psychiatr. Scand. 73: 17-21, 1986.
30. 2 receptors. Psychopharmacology 112: S40-S54, 1993.
31. LINK, C., ARVANITIS, L., MILLER, B. AND FENNIMORE, J.: Seroquel Study Group: A multicentre, placebo-controlled, double-blind evaluation of Seroquel in hospitalised patients with acute exacerbation of chronic and subchronic schizophrenia. Eur. Neuropsychopharmacol. 4: 385-386, 1994.
32. MANSBACH, R. S. AND GEYER, M. A.: Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2: 299-308, 1989.
33. MANSBACH, R. S., GEYER, M. A. AND BRAFF, D. L.: Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94: 507-514, 1988.
34. MIGLER, B. M., WARAWA, E. J. AND MALICK, J. B.: Seroquel: Behavioral effects in conventional and novel tests for atypical antipsychotic drug. Psychopharmacology 112: 229-307, 1993.
35. MOORE, N. A., CALLIGARO, D. O., WONG, D. T., BYMASTER, F. AND TYE, N. C.: The pharmacology of olanzapine and other new antipsychotic agents. Curr. Opin. Invest. Drugs 2: 281-293, 1993.
36. MOORE, N. A., TYE, N. C., AXTON, M. S. AND RISIUS, F. C.: The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J. Pharmacol. Exp. Ther. 262: 545-551, 1992.
37. RADFORD, J. M., BROWN, T. M. AND BORISON, R. L.: Unexpected dystonia while changing from clozapine to risperidone. J. Clin. Psychopharmacol. 15: 225-226, 1995.
38. REBEC, G. V., ALLOWAY, K. D. AND BASHORE, T. R.: Differential actions of classical and atypical antipsychotic drugs on spontaneous neuronal activity in the amygdaloid complex. Pharmacol. Biochem. Behav. 14: 49-56, 1981.
39. RICH, S. S., FRIEDMAN, J. H. AND OTT, B. R.: Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes. J. Clin. Psychiatry 56: 556-559, 1995.
40. RIGDON, G. C. AND VIIK, K.: Prepulse inhibition as a screening test for potential antipsychotics. Drug Res. Dev. 23: 91-99, 1991.
41. ROTH, B. L., TANDRA, S., BURGESS, L. H., SIBLEY, D. R. AND MELTZER, H. Y.: D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Psychopharmacology 120: 365-368, 1995.
42. SALLER, C. F. AND SALAMA, A. I.: Seroquel: Biochemical profile of a potential atypical antipsychotic. Psychopharmacology 112: 285-292, 1993.
43. SCHWARZKOPF, S. B., AL-AMIN, H. A. AND ISON, J. R.: Clozapine, but not D1/D2 antagonists, reverses sensorimotor gating deficits and hypermotility induced by an NMDA antagonist: Pathophysiologic implications. Soc. Neurosci. Abstr. 20: 25, 1994.
44. SCHWARZKOPF, S. B., MCCOY, L., SMITH, D. A. AND BOUTROS, N. N.: Test-retest reliability of prepulse inhibition of the acoustic startle response. Biol. Psychiatry 34: 896-900, 1993.
45. SWERDLOW, N. R., BAKSHI, V. P. AND GEYER, M. A.: Seroquel restores prepulse inhibition and habituation of startle in phencyclidine-treated rats: Profile of an "atypical" antipsychotic. In Proceedings of the American College of Neuropsychopharmacology Meeting, American College of Neuropsychopharmacology, 1995, p. 277.
46. SWERDLOW, N. R., BRAFF, D. L., GEYER, M. A. AND KOOB, G. F.: Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol. Psychiatry 21: 23-33, 1986.
47. SWERDLOW, N. R., BRAFF, D. L., TAAID, N. AND GEYER, M. A.: Assessing the validity of an animal model of sensorimotor gating deficits in schizophrenic patients. Arch. Gen. Psychiatry 51: 139-154, 1994a.
48. SWERDLOW, N. R., CAINE, S. B., BRAFF, D. L. AND GEYER, M. A.: Neural substrates of sensorimotor gating of the startle reflex: A review of recent findings and their implications. J. Psychopharmacol. 6: 176-190, 1992.
49. SWERDLOW, N. R. AND GEYER, M. A.: Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol. Biochem. Behav. 44: 741-744, 1993.
50. SWERDLOW, N. R., KEITH, V. A., BRAFF, D. L. AND GEYER, M. A.: The effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine-inhibition of sensorimotor gating of the startle response in the rat. J. Pharmacol. Exp. Ther. 256: 530-536, 1991.
51. SWERDLOW, N. R., MANSBACH, R. S., GEYER, M. A., PULVIRENTI, L., KOOB, G. F. AND BRAFF, D. L.: Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology 100: 413-416, 1990.
52. SWERDLOW, N. R., ZISOOK, D. AND TAAID, N.: Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: Similarities to clozapine. Psychopharmacology 114: 675-678, 1994b.
53. VARTY, G. B. AND HIGGINS, G. A.: Examination of drug-induced and isolationinduced disruptions of PPI as models to screen antipsychotic drugs. Psychopharmacology 122: 15-26, 1995.
54. WARAWA, E. AND MIGLER, B.: Novel dibenzothiazepine antipsychotic. United States Patent 4,879,288, 1989.